Inventor · disambiguated record
Paul Beckett
Also filed as: BECKETT PAUL · BECKETT PAUL RAYMOND
12 granted patents·9 pending applications·34 citations·filing 2001–2024
88Inventor score
Files withLAM THERAPEUTICS INC5AI THERAPEUTICS INC4BRITISH BIOTECH PHARM4AI Therapeutics2AL THERAPEUTICS INC2
Top patents by PatentIndex Score
21 records- 0190US10206910B2Apilimod for use in the treatment of renal cancerLAM THERAPEUTICS INC·Filed 2015·Granted Feb 19, 2019·10 cites·15 claims
- 0288US10765682B2Apilimod for use in the treatment of melanomaLAM THERAPEUTICS INC·Filed 2015·Granted Sep 8, 2020·4 cites·11 claims
- 0387US11266654B2Apilimod compositions and methods for using sameAI THERAPEUTICS INC·Filed 2019·Granted Mar 8, 2022·2 cites·9 claims
- 0482US10350213B2Methods for treating cancer using apilimodAI THERAPEUTICS INC·Filed 2016·Granted Jul 16, 2019·4 cites·4 claims
- 0582US10179135B2Apilimod compositions and methods for using sameLAM THERAPEUTICS INC·Filed 2015·Granted Jan 15, 2019·4 cites·18 claims
- 0679US9440953B2Substituted amino triazoles useful as acidic mammalian chitinase inhibitorsONCOARENDI THERAPEUTICS SP Z O O·Filed 2015·Granted Sep 13, 2016·4 cites·33 claims
- 0779US9040703B2Inhibitors of arginase and their therapeutic applicationsVAN ZANDT MICHAEL·Filed 2011·Granted May 26, 2015·4 cites·2 claims
- 0873US10729694B2Anti-viral compositions containing PIKfyve inhibitors and use thereofAI THERAPEUTICS INC·Filed 2016·Granted Aug 4, 2020·1 cites·16 claims
- 0969US11166944B2Apilimod compositions and methods for using same in the treatment of renal cancerAI Therapeutics·Filed 2019·Granted Nov 9, 2021·0 cites·11 claims
- 1067US7173053B2N-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide formylase for treating microbial infectionsBRITISH BIOTECH PHARM·Filed 2001·Granted Feb 6, 2007·1 cites·8 claims
- 1166US2024277720A1Stabilized apilimod compositions and uses thereofORPHAI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1259US2020360397A1Anti-viral compositions containing pikfyve inhibitors and use thereofAI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1358US2024374523A1Stabilized apilimod compositions and uses thereofORPHAI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1456US2009069322A1N-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide formylase for treating microbial infectionsBRITISH BIOTECH PHARM·Filed 2006·Application pending·0 cites
- 1555US7323563B2Hydroxamic acid derivatives as antibacterialsBRITISH BIOTECH PHARM·Filed 2005·Granted Jan 29, 2008·0 cites·8 claims
- 1652US2019183902A1Apilimod Compositions and Methods for Using SameAL THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1751US6992190B2Hydroxamic acid derivatives as antibacterialsBRITISH BIOTECH PHARM·Filed 2002·Granted Jan 31, 2006·0 cites·7 claims
- 1850US2019201385A1Apilimod for use in the treatment of renal cancerAI Therapeutics·Filed 2018·Application pending·0 cites
- 1942US2019015421A1Biomarkers for Treating Cancer with ApilimodLAM THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2042US2020261427A1Topical rapamycin formulations and their use in treating facial angiofibromas and other skin disordersAL THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2135US2018078561A1Active metabolites of apilimod and uses thereofLAM THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul Beckett files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →